Author:
Duceau Baptiste,Welschbillig Stephane,Engrand Nicolas,Godier Anne
Publisher
Springer Science and Business Media LLC
Subject
Clinical Neurology,Surgery
Reference10 articles.
1. Drake TA, Morrissey JH, Edgington TS (1989) Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 134(5):1087–1097
2. Felfernig M, Huepfl M (2008) Experience of recombinant activated factor VII (NovoSeven) in the operating theatre and intensive care unit for the management of intracranial bleeding in nonhaemophilic patients. Clin Neurol Neurosurg 110(3):227–232
3. Hartmann M, Sucker C, Messing M (2006) Recombinant activated factor VII in the treatment of near-fatal bleeding during pediatric brain tumor surgery. Report of two cases and review of the literature. J Neurosurg 104(1 Suppl):55–58
4. Heisel M, Nagib M, Madsen L, Alshiekh M, Bendel A (2004) Use of recombinant factor VIIa (rFVIIa) to control intraoperative bleeding in pediatric brain tumor patients. Pediatr Blood Cancer 43(6):703–705
5. Kapapa T, König K, Heissler HE, Schatzmann C, Tschan CA, Perl M, von Depka M, Zumkeller M, Rickels E (2009) The use of recombinant activated factor VII in neurosurgery. Surg Neurol 71(2):172–179, discussion 179